Form D · Biotechnology

CORGENIX MEDICAL CORP/CO

Broomfield, CO · CIK 0001063665

Offering snapshot reported Jul 30, 2010 · SEC filing

Reported sold
$1.25M
Offering amount: $3M
Investors reported
1
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jul 16, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 30, 2010Initial$1,250,000No comparison1SEC filing
Jul 25, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 12, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jun 6, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-145737

Source: Form D, filed Jul 30, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
William H. Critchfield Executive
Stephen P. Gouze Director
David C. Kikumoto Director
Luis R. Lopez Director, Executive
Larry G. Rau Director
Taryn G. Reynolds Executive
Douglass T. Simpson Director, Executive
Ann L. Steinbarger Executive
Robert Tutag Director
Dennis Walczewski Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11575 Main Street, Suite 400
Broomfield, CO, 80020